Older age, prior heart failure (HF) and CV events, peripheral artery disease, and kidney complications can identify a subgroup of patients with T2D at high risk of mortality who are likely to achieve the greatest benefit from newer glucose-lowering agents
This article summarises the position reached with the GLP-1 RAs and reviews the developing field of unimolecular co-agonists that act not only on the GLP-1 receptor, but on other receptors, notably glucose-dependent insulotropic polypeptide (GIP) and glucagon receptors, with the aim of further improving glycaemic control and weight reduction
Frequently Asked Questions About Infusion Therapy How long does an iv therapy session take
Kidney infection is the most common cause of septic shock (severe drop in blood pressure) in pregnant women
When measuring GSH content, a suitable, sensitive, and precise detection method should be selected based on the actual situation
Its gentle effect on the body makes it suitable for consistent use over time, especially when the goal is long-term wellness, recovery, or hormone balance